Anti-Hypertensive



Betabest AM 25

Betabest AM 25

Description

Fixed dose combination of Amlodipine (calcium channel blocker) and Metoprolol (cardioselective beta blocker). Controls all major factors influencing blood pressure including peripheral vascular resistance, stroke volume and heart rate. Produces synergistic action with lower incidence of individual drug side effects and improved patient compliance.

Indications

  • Hypertension uncontrolled on monotherapy
  • Hypertension with ischemic heart disease

Composition (per tablet)

  • Metoprolol succinate (Extended release) — 25 mg
  • Amlodipine — 5 mg

Dosage

One tablet once daily (or individualized by physician).

Side Effects

Dizziness, headache, nausea, diarrhoea, fatigue, edema, flushing, palpitations, cold extremities.

Contraindications

Hypersensitivity to any component. Severe bradycardia, heart block > 1st degree, cardiogenic shock, refractory heart failure, sick sinus syndrome.

Presentation

Strip of 10 tablets.

Request Information


“For Healthcare Professionals & Business Partners Only”

Betabest AM 50

Betabest AM 50

Description

Combination of Amlodipine and high-dose Metoprolol for more resistant hypertension offering dual mechanism action and improved BP target achievement.

Indications

  • Hypertension uncontrolled on monotherapy
  • Hypertension with ischemic heart disease

Composition (per tablet)

  • Metoprolol succinate (Extended release) — 50 mg
  • Amlodipine — 5 mg

Dosage

One tablet once daily (or individualized by physician).

Side Effects

Dizziness, headache, nausea, diarrhoea, fatigue, edema, flushing, palpitations, cold extremities.

Contraindications

Same contraindications as Betabest AM 25.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Betabest XL 25

Betabest XL 25

Description

Extended-release Metoprolol formulated for controlled & predictable release ensuring once-daily BP control with high tolerability.

Indications

  • Hypertension
  • Angina pectoris
  • Heart failure
  • Post-MI

Composition (per tablet)

  • Extended release Metoprolol succinate — 25 mg

Dosage

As directed by physician depending on condition.

Side Effects

Tiredness, dizziness, depression, headache, bradycardia, nausea, diarrhoea, constipation, flatulence.

Contraindications

Severe bradycardia, heart block > 1st degree, cardiogenic shock, sick sinus syndrome, refractory heart failure, hypersensitivity to formulation.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Betabest XL 50

Betabest XL 50

Description

Extended-release Metoprolol for more advanced hypertension & angina treatment with controlled plasma levels for 24-hour coverage.

Indications

  • Hypertension
  • Angina pectoris
  • Heart failure
  • Post-MI

Composition (per tablet)

  • Extended release Metoprolol succinate — 50 mg

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CT 40-12.5

Omen CT 40-12.5

Indications

  • Hypertension uncontrolled with monotherapy

Composition (per tablet)

  • Olmesartan medoxomil — 40 mg
  • Chlorthalidone — 12.5 mg

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CT 20-6.25

Omen CT 20-6.25

Indications

  • Mild to moderate hypertension

Composition (per tablet)

  • Olmesartan medoxomil — 20 mg
  • Chlorthalidone — 6.25 mg

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CT 40-6.25

Omen CT 40-6.25

Indications

  • Mild to moderate hypertension

Composition (per tablet)

  • Olmesartan medoxomil — 40 mg
  • Chlorthalidone — 6.25 mg

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CDP 20

Omen CDP 20

Indications

  • Stage II hypertension
  • Hypertension with CKD
  • Hypertension uncontrolled with monotherapy
  • Diabetic hypertensive patients

Composition (per tablet)

  • Olmesartan medoxomil — 20 mg
  • Cilnidipine — 10 mg

Presentation

Omen CDP 20 is available in a strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CDP 40

Omen CDP 40

Indications

  • Stage II hypertension
  • Hypertension with CKD
  • Hypertension uncontrolled with monotherapy
  • Diabetic hypertensive patients

Composition (per tablet)

  • Olmesartan medoxomil — 40 mg
  • Cilnidipine — 10 mg

Presentation

Omen CDP 40 is available in a strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen 20

Omen 20

Description

Olmesartan controls hypertension by inhibiting the renin-angiotensin-aldosterone system. Highly effective and well tolerated in diabetic and non-diabetic patients.

Indications

  • Mild to moderate hypertension

Composition (per tablet)

  • Olmesartan — 20 mg

Dosage & Administration

One tablet once daily; consistent timing recommended for stable plasma concentration.

Contraindications

Hypersensitivity to formulation, pregnancy, and severe renal impairment.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen 40

Omen 40

Description

Higher-strength Olmesartan providing potent RAAS inhibition and BP reduction. Proven tolerability in both diabetic and non-diabetic hypertension.

Indications

  • Mild to moderate hypertension

Composition (per tablet)

  • Olmesartan — 40 mg

Dosage & Administration

One tablet once daily at the same time each day.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen AM

Omen AM

Description

Combination of Olmesartan and Amlodipine for complementary BP reduction. Reduces pedal edema associated with amlodipine due to balance of arterio- and veno-dilatation.

Indications

  • Hypertension
  • Stage II hypertension

Composition (per tablet)

  • Olmesartan — 10 mg
  • Amlodipine — 5 mg

Dosage

One tablet once daily.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen AM 20

Omen AM 20

Indications

  • Hypertension associated with diabetes

Composition (per tablet)

  • Olmesartan — 20 mg
  • Amlodipine — 5 mg

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen CT

Omen CT

Description

Dual-mechanism blood pressure control: Olmesartan inhibits RAAS and Chlorthalidone promotes natriuresis and diuresis delivering additive antihypertensive effect.

Indications

  • Hypertension uncontrolled with monotherapy

Composition (per tablet)

  • Olmesartan medoxomil — 20 mg
  • Chlorthalidone — 12.5 mg

Dosage

One tablet once daily.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Omen ACT

Omen ACT

Description

Triple therapy for difficult-to-control hypertension: Olmesartan (RAAS blocker) + Amlodipine (calcium channel blocker) + Chlorthalidone (thiazide-like diuretic). Balances potassium levels by opposing effects of amlodipine-induced edema.

Indications

  • Hypertension uncontrolled on dual therapy
  • Refractory hypertension

Composition (per tablet)

  • Olmesartan — 20 mg
  • Amlodipine — 5 mg
  • Chlorthalidone — 12.5 mg

Dosage

One tablet once daily.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”

Primodil AT

Primodil AT

Description

Amlodipine reduces blood pressure by vasodilation while Atenolol decreases heart rate and cardiac workload. The combination also provides strong protection in ischemic heart disease by balancing oxygen supply and demand.

Indications

  • Hypertension with ischemic heart disease

Composition (per tablet)

  • Amlodipine — 5 mg
  • Atenolol — 50 mg

Dosage

Once daily (hypertension and angina).

Side Effects

Headache, ankle edema.

Contraindications

Hypersensitivity to either drug, congestive cardiac failure, pregnancy and lactation.

Presentation

Strip of 10 tablets.


“For Healthcare Professionals & Business Partners Only”



Company Identification Number
( CIN ) : U24230MH1975PLC018296

Connect With Us

Contact Us


Medley House, D2,
M.I.D.C. Area,
Andheri (East),
Mumbai-400 093, INDIA




All © Rights Reserved by Medley Pharmaceuticals Ltd.

Designed By Mirackle Solutions